CNO Financial Group, Inc. SEC Filings

CNO Financial Group, Inc. (CNO) disclosed that officer Karen DeToro filed a notice to sell CNO common stock under Rule 144. She lists 9,336 shares of common stock held through Morgan Stanley Smith Barney Executive Financial Services, with an indicated value of $511,002.96 as of September 1, 2026. Planned sales include 1,836 shares from restricted stock dated March 25, 2025 and 7,500 shares issuable upon a stock option exercise dated September 1, 2026. The notice also reports a prior sale of 9,374 shares on August 31, 2026 for $515,366.21.

CNO Financial Group, Inc. (CNO) furnished an investor briefing focused on its Worksite Division and Medicare business, highlighting its middle‑income market strategy and distribution model. The company employs approximately 3,200 associates, contracts with over 11,500 agents and independent partners, has a $5.1 billion market capitalization, and reports $39.9 billion in total assets as of June 30, 2026. Customers own 3.3 million policies, and CNO paid $2.1 billion in claims in 2025.

The Worksite Division targets employers with predominantly middle‑income workforces, with almost 70% of new annualized premium (NAP) from transit and utilities, education, and public sector employers, and has grown Worksite NAP at an 18% CAGR since 2020. CNO emphasizes supplemental health and life products, including return‑of‑premium features that have returned nearly $5 billion of premium to policyholders since inception.

In Medicare, CNO describes a large, growing market of over 69 million beneficiaries, with Medicare spending above $1.2 trillion. CNO distributes its own Medicare Supplement plans and a wide range of third‑party Medicare Advantage and prescription drug plans through more than 5,000 captive health insurance agents, and presents data on growing Medicare Supplement enrollment, earned premiums and underwriting margins.

CNO Financial Group, Inc. (CNO) is the issuer in a notice filed for a proposed sale of its common stock under Rule 144 by officer Karen DeToro. The notice covers up to 9,374 shares of common stock, with an aggregate market value of $515,366.21, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or after August 31, 2026. The shares consist of 7,500 shares underlying stock options expected to be exercised for cash on August 31, 2026, and 1,874 shares of restricted stock issuable on March 25, 2025.

CNO Financial Group, Inc. (CNO) is the issuer of common stock that officer Jeanne Lynn Linnenbringer has filed a notice to potentially sell under Rule 144. The notice covers up to 6,560 shares of CNO common stock, with an indicated aggregate market value of $360,715.51, and lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker. The shares relate to 5,010 shares from a stock option exercise dated August 31, 2026 and 1,550 performance shares dated February 15, 2022, with a proposed sale date of August 31, 2026 on the NYSE.

CNO Financial Group, Inc. filed a quarterly Form 13F institutional investment manager holdings report. The report covers 18 reportable positions with a total reported value of 174,661,572 (round to the nearest dollar). The filing also notes 1 other included manager, 40/86 Advisors, Inc.

CNO Financial Group, Inc. reported higher results for the quarter and six months ended June 30, 2026. Total revenues were $1,285.2 million for the quarter, up from $1,151.5 million a year earlier, and net income rose to $125.9 million from $91.8 million, with diluted EPS increasing to $1.33 from $0.91. For the first six months, revenues were $2,314.8 million and net income $163.6 million, compared to $2,155.6 million and $113.3 million in 2025.

Total assets increased to $39,861.2 million as of June 30, 2026, while shareholders’ equity was $2,591.6 million. The investment portfolio reached $30,742.9 million, and cash and cash equivalents (including those held by variable interest entities) were $1,306.0 million. The company continued returning capital through common stock repurchases of $120.0 million and common dividends of $33.5 million in the first half of 2026, and exited its Worksite fee services business as of June 30, 2026.

CNO Financial Group, Inc. reported strong second quarter 2026 results and raised its 2026 operating earnings per share guidance by 8% at the midpoint. Net income was $125.9 million, or $1.33 per diluted share, and net operating income was $119.5 million, or $1.26 per diluted share.

Total revenues were $1,285.2 million, and operating EPS grew 45% year-over-year. The trailing four-quarter return on equity was 10.9%, with operating ROE excluding significant items at 13.1%. Book value per diluted share excluding accumulated other comprehensive loss was $39.92. New annualized premiums rose 7%, marking the 16th consecutive quarter of insurance sales growth. CNO repurchased $60.0 million of common stock and paid $16.8 million in common dividends during the quarter.

CNO submitted a Form 144 notice reporting the proposed sale of restricted common stock and recent dispositions by a holder. The filing lists three past transfers in June 2026: 5,750 shares ($287,500) on 06/11/2026, 3,308 shares ($162,092) on 06/10/2026, and 4,808 shares ($225,976) on 06/02/2026. The header lists 93,348,503 shares with an associated date of 07/01/2026.

CNO Financial Group CEO Gary C. Bhojwani reported a combination of option exercises and stock sales. He exercised 44,250 Employee Stock Options at an exercise price of $21.06 per share, converting them into common stock, and then sold a total of 86,048 common shares in two open-market transactions at weighted average prices of about $51.48 per share pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026. After these transactions, he held 174,264 common shares directly and 651,189 common shares indirectly through the Gary C. Bhojwani Revocable Trust.